Skip to content

Clinical registration study of risk factors for progression of cerebral artery stenosis

Clinical registration study of risk factors for progression of cerebral artery stenosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068629
Enrollment
Unknown
Registered
2023-02-26
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral arterial stenosis

Interventions

Case series:Nil

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. At least one intracranial and/or extracranial artery stenosis (>=30%) confirmed by cervical vascular ultrasound, CTA, MRA, TCD or DSA; 3. Great compliance, agreed to sign informed consent and accept follow-up. Note: Intracranial arteries include: intracranial internal carotid artery (C4-C7 and T segment), middle cerebral artery(M1 and M2), anterior cerebral artery (A1 and A2),posterior cerebral artery (P1 and P2 ), and basilar artery. The extracranial arteries included internal carotid artery C1-C3 and vertebral artery V1-V3 . The internal carotid artery was segmented by Bouthillier method.

Exclusion criteria

Exclusion criteria: 1. ?Suffering from other known serious life threatening diseases (such as hematological diseases, malignant tumors), unstable vital signs or in need of continuous monitoring or in a dying state; 2. Arterial stenosis or occlusion ?by non-atherosclerosis diseases, such as arterial dissection, moya-Moya disease, vasculitis, radioactive vascular disease, or fibromuscular dysplasia; 3. Complicated with intracranial tumor, aneurysm or intracranial arteriovenous malformation; 4. There are risk factors that may lead to cardiogenic embolism, such as atrial fibrillation, left ventricular thrombosis, myocardial infarction within 6 weeks, etc. 5. Those who are pregnant, breast-feeding and planning pregnancy; 6. Patients have been included in other studies that conflict with this study; 7. Other conditions that the investigator considered inappropriate for enrollment.

Design outcomes

Primary

MeasureTime frame
Characteristics and composition of atherosclerotic plaques in intracranial and/or extracranial arteries;Degree of intracranial/external vascular stenosis;

Secondary

MeasureTime frame
blood pressure;fasting blood glucose;white blood cell count;Red Blood Cell Count;hemoglobin;platelet count;alanine transaminase;aspartate aminotransferase;creatine kinase;total cholesterol;triglyeride;low-density lipoprotein;high-density lipoprotein;creatinine;uric acid;

Countries

China

Contacts

Public ContactBo Hu

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

hubo@mail.hust.edu.cn13707114863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026